![Cancers | Free Full-Text | Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis Cancers | Free Full-Text | Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis](https://www.mdpi.com/cancers/cancers-12-03790/article_deploy/html/images/cancers-12-03790-g001.png)
Cancers | Free Full-Text | Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis
![Prediction of prostate cancer recurrence using quantitative phase imaging: Validation on a general population | Scientific Reports Prediction of prostate cancer recurrence using quantitative phase imaging: Validation on a general population | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep33818/MediaObjects/41598_2016_Article_BFsrep33818_Fig1_HTML.jpg)
Prediction of prostate cancer recurrence using quantitative phase imaging: Validation on a general population | Scientific Reports
![Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care](https://cambridgeprostatecancer.com/wp-content/uploads/cam1-min-768x431.jpg)
Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care
![CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2011/06/capra-s-rev.png)
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
![Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer](https://www.mdpi.com/cells/cells-09-02116/article_deploy/html/images/cells-09-02116-g001.png)
Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
Indonesian Prostate Cancer Risk Calculator (IPCRC): An application for Predicting Prostate Cancer Risk (a Multicenter Study)
![Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer - European Urology Focus Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/1859b97d-834f-4585-a101-d7d5749dbf86/gr1_lrg.jpg)
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer - European Urology Focus
![The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41585-020-0349-1/MediaObjects/41585_2020_349_Fig1_HTML.png)
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1c.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
![JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy](https://www.mdpi.com/jpm/jpm-09-00019/article_deploy/html/images/jpm-09-00019-g002.png)
JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
![Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care](https://cambridgeprostatecancer.com/wp-content/uploads/CPG-chart.jpg)
Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care
![Frontiers | Prognostic Models for Patients With Gleason Score 9 Prostate Cancer: A Population-Based Study Frontiers | Prognostic Models for Patients With Gleason Score 9 Prostate Cancer: A Population-Based Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/633312/633312_Thumb_400.jpg)